Company · CIK 0001517022 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Akebia Therapeutics, Inc. · AKBA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 MForm 4 → | Aug 10, 4:08 pm EDT | John P. ButlerCEO and President, Director | 350,000 | $0.63 | $220,500 | 3,718,564 | — | |
| Jun 29, 2026 SForm 4 → | Jul 1, 4:34 pm EDT | Erik OstrowskiSVP, CFO, CBO & Treasurer | 56,019 | $1.11 | $62,181 | 616,616 | −8.33% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 MForm 4 → | Aug 10, 4:08 pm EDT | John P. ButlerCEO and President, Director | 350,000 | — | — | 525,000 | — |